• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期静脉输液量与伴或不伴心力衰竭的脓毒症患者住院结局的相关性:一项回顾性队列研究。

Associations Between Volume of Early Intravenous Fluid and Hospital Outcomes in Septic Patients With and Without Heart Failure: A Retrospective Cohort Study.

机构信息

Department of Medicine, University of California, San Francisco, San Francisco, CA.

Division of Hospital Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA.

出版信息

Crit Care Explor. 2024 Apr 26;6(5):e1082. doi: 10.1097/CCE.0000000000001082. eCollection 2024 May.

DOI:10.1097/CCE.0000000000001082
PMID:38694845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11057813/
Abstract

OBJECTIVES

To evaluate the relationship between early IV fluid volume and hospital outcomes, including death in-hospital or discharge to hospice, in septic patients with and without heart failure (HF).

DESIGN

A retrospective cohort study using logistic regression with restricted cubic splines to assess for nonlinear relationships between fluid volume and outcomes, stratified by HF status and adjusted for propensity to receive a given fluid volume in the first 6 hours. An ICU subgroup analysis was performed. Secondary outcomes of vasopressor use, mechanical ventilation, and length of stay in survivors were assessed.

SETTING

An urban university-based hospital.

PATIENTS

A total of 9613 adult patients were admitted from the emergency department from 2012 to 2021 that met electronic health record-based Sepsis-3 criteria. Preexisting HF diagnosis was identified by the codes.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

There were 1449 admissions from patients with HF. The relationship between fluid volume and death or discharge to hospice was nonlinear in patients without HF, and approximately linear in patients with HF. Receiving 0-15 mL/kg in the first 6 hours was associated with lower likelihood of death or discharge to hospice compared with 30-45 mL/kg (odds ratio = 0.61; 95% CI, 0.41-0.90; = 0.01) in HF patients, but no significant difference for non-HF patients. A similar pattern was identified in ICU admissions and some secondary outcomes. Volumes larger than 15-30 mL/kg for non-HF patients and 30-45 mL/kg for ICU-admitted non-HF patients were not associated with improved outcomes.

CONCLUSIONS

Early fluid resuscitation showed distinct patterns of potential harm and benefit between patients with and without HF who met Sepsis-3 criteria. Restricted cubic splines analysis highlighted the importance of considering nonlinear fluid outcomes relationships and identified potential points of diminishing returns (15-30 mL/kg across all patients without HF and 30-45 mL/kg when admitted to the ICU). Receiving less than 15 mL/kg was associated with better outcomes in HF patients, suggesting small volumes may be appropriate in select patients. Future studies may benefit from investigating nonlinear fluid-outcome associations and a focus on other conditions like HF.

摘要

目的

评估有和没有心力衰竭(HF)的败血症患者早期静脉输液量与住院结局(包括院内死亡或临终关怀出院)之间的关系。

设计

一项回顾性队列研究,使用逻辑回归和限制立方样条评估液体量与结局之间的非线性关系,按 HF 状态分层,并根据前 6 小时内接受特定液体量的倾向进行调整。进行了 ICU 亚组分析。评估存活者的血管加压药使用、机械通气和住院时间等次要结局。

地点

一所城市大学附属医院。

患者

共有 9613 名成年患者从 2012 年至 2021 年从急诊科入院,符合电子病历为基础的 Sepsis-3 标准。预先存在的 HF 诊断通过 代码确定。

干预措施

无。

测量和主要结果

HF 患者中有 1449 例住院。无 HF 患者的液体量与死亡或临终关怀出院之间的关系是非线性的,而 HF 患者的关系则是近似线性的。与 30-45 mL/kg 相比,前 6 小时内接受 0-15 mL/kg 输液与 HF 患者的死亡或临终关怀出院的可能性较低相关(比值比=0.61;95%CI,0.41-0.90; = 0.01),而非 HF 患者则无显著差异。在 ICU 入院和一些次要结局中也发现了类似的模式。对于非 HF 患者,体积大于 15-30 mL/kg,对于 ICU 入院的非 HF 患者,体积大于 30-45 mL/kg,与改善结局无关。

结论

符合 Sepsis-3 标准的有和没有 HF 的败血症患者早期液体复苏表现出明显的潜在危害和获益模式。限制立方样条分析强调了考虑非线性液体结局关系的重要性,并确定了潜在的收益递减点(所有非 HF 患者为 15-30 mL/kg,当 ICU 入院时为 30-45 mL/kg)。HF 患者接受少于 15 mL/kg 与更好的结局相关,这表明在某些选择的患者中,小体积可能是合适的。未来的研究可能受益于调查非线性液体-结局关联,并关注其他疾病如 HF。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac31/11057813/90b465e7ce4c/cc9-6-e1082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac31/11057813/223ae3dcbf11/cc9-6-e1082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac31/11057813/d42d7e1e4c36/cc9-6-e1082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac31/11057813/90b465e7ce4c/cc9-6-e1082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac31/11057813/223ae3dcbf11/cc9-6-e1082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac31/11057813/d42d7e1e4c36/cc9-6-e1082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac31/11057813/90b465e7ce4c/cc9-6-e1082-g003.jpg

相似文献

1
Associations Between Volume of Early Intravenous Fluid and Hospital Outcomes in Septic Patients With and Without Heart Failure: A Retrospective Cohort Study.早期静脉输液量与伴或不伴心力衰竭的脓毒症患者住院结局的相关性:一项回顾性队列研究。
Crit Care Explor. 2024 Apr 26;6(5):e1082. doi: 10.1097/CCE.0000000000001082. eCollection 2024 May.
2
Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database.严重脓毒症和脓毒性休克中的液体管理、模式和结局:对大型国家数据库的分析。
Intensive Care Med. 2017 May;43(5):625-632. doi: 10.1007/s00134-016-4675-y. Epub 2017 Jan 27.
3
Assessment of Outcomes in Patients with Heart Failure and End-Stage Kidney Disease after Fluid Resuscitation for Sepsis and Septic Shock.评估脓毒症和感染性休克液体复苏后心力衰竭和终末期肾病患者的结局。
J Emerg Med. 2024 Jun;66(6):e670-e679. doi: 10.1016/j.jemermed.2024.02.001. Epub 2024 Feb 16.
4
Association Between Volume of Fluid Resuscitation and Intubation in High-Risk Patients With Sepsis, Heart Failure, End-Stage Renal Disease, and Cirrhosis.容量复苏与高危患者脓毒症、心力衰竭、终末期肾病和肝硬化患者插管的关系。
Chest. 2020 Feb;157(2):286-292. doi: 10.1016/j.chest.2019.09.029. Epub 2019 Oct 14.
5
Evaluation and Predictors of Fluid Resuscitation in Patients With Severe Sepsis and Septic Shock.严重脓毒症和脓毒性休克患者液体复苏的评估和预测因素。
Crit Care Med. 2019 Nov;47(11):1582-1590. doi: 10.1097/CCM.0000000000003960.
6
Multicenter observational study of the development of progressive organ dysfunction and therapeutic interventions in normotensive sepsis patients in the emergency department.多中心观察性研究:正常血压脓毒症患者在急诊科进展性器官功能障碍的发生和治疗干预。
Acad Emerg Med. 2013 May;20(5):433-40. doi: 10.1111/acem.12137.
7
Patterns and Outcomes Associated With Timeliness of Initial Crystalloid Resuscitation in a Prospective Sepsis and Septic Shock Cohort.前瞻性脓毒症和脓毒性休克队列中初始晶体液复苏及时性相关的模式及结果
Crit Care Med. 2017 Oct;45(10):1596-1606. doi: 10.1097/CCM.0000000000002574.
8
Fluid resuscitation and outcomes in heart failure patients with severe sepsis or septic shock: A retrospective case-control study.严重脓毒症或感染性休克心力衰竭患者的液体复苏与结局:一项回顾性病例对照研究。
PLoS One. 2021 Aug 19;16(8):e0256368. doi: 10.1371/journal.pone.0256368. eCollection 2021.
9
Association Between Preexisting Heart Failure With Reduced Ejection Fraction and Fluid Administration Among Patients With Sepsis.患有脓毒症的患者中,射血分数降低的心力衰竭与液体管理之间的关系。
JAMA Netw Open. 2022 Oct 3;5(10):e2235331. doi: 10.1001/jamanetworkopen.2022.35331.
10
Resuscitating patients with early severe sepsis: a Canadian multicentre observational study.对早期重症脓毒症患者进行复苏:一项加拿大多中心观察性研究。
Can J Anaesth. 2007 Oct;54(10):790-8. doi: 10.1007/BF03021706.

引用本文的文献

1
European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients: part 2-the volume of resuscitation fluids.欧洲重症监护医学学会(ESICM)2025年成人危重症患者液体治疗临床实践指南:第2部分——复苏液体量
Intensive Care Med. 2025 Mar;51(3):461-477. doi: 10.1007/s00134-025-07840-1. Epub 2025 Mar 31.
2
Unsupervised learning-derived phenotypes for personalized fluid management in critically ill patients with heart failure: A multicenter study.基于无监督学习得出的心力衰竭重症患者个性化液体管理表型:一项多中心研究。
Clin Transl Med. 2024 Nov;14(11):e70081. doi: 10.1002/ctm2.70081.

本文引用的文献

1
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.脓毒症性低血压的早期限制或宽松液体管理。
N Engl J Med. 2023 Feb 9;388(6):499-510. doi: 10.1056/NEJMoa2212663. Epub 2023 Jan 21.
2
Association Between Preexisting Heart Failure With Reduced Ejection Fraction and Fluid Administration Among Patients With Sepsis.患有脓毒症的患者中,射血分数降低的心力衰竭与液体管理之间的关系。
JAMA Netw Open. 2022 Oct 3;5(10):e2235331. doi: 10.1001/jamanetworkopen.2022.35331.
3
Restriction of Intravenous Fluid in ICU Patients with Septic Shock.
ICU 脓毒性休克患者的静脉液体限制。
N Engl J Med. 2022 Jun 30;386(26):2459-2470. doi: 10.1056/NEJMoa2202707. Epub 2022 Jun 17.
4
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143. doi: 10.1097/CCM.0000000000005337.
5
Fluid resuscitation and outcomes in heart failure patients with severe sepsis or septic shock: A retrospective case-control study.严重脓毒症或感染性休克心力衰竭患者的液体复苏与结局:一项回顾性病例对照研究。
PLoS One. 2021 Aug 19;16(8):e0256368. doi: 10.1371/journal.pone.0256368. eCollection 2021.
6
Improvement in Mortality With Early Fluid Bolus in Sepsis Patients With a History of Congestive Heart Failure.有充血性心力衰竭病史的脓毒症患者早期给予液体冲击治疗可改善死亡率。
Mayo Clin Proc Innov Qual Outcomes. 2020 Aug 19;4(5):537-541. doi: 10.1016/j.mayocpiqo.2020.05.008. eCollection 2020 Oct.
7
Fluid resuscitation in sepsis: the great 30 mL per kg hoax.脓毒症中的液体复苏:每千克30毫升的大骗局。
J Thorac Dis. 2020 Feb;12(Suppl 1):S37-S47. doi: 10.21037/jtd.2019.12.84.
8
Variability in usual care fluid resuscitation and risk-adjusted outcomes for mechanically ventilated patients in shock.机械通气休克患者常规液体复苏的变异性和风险调整结局。
Crit Care. 2020 Jan 28;24(1):25. doi: 10.1186/s13054-020-2734-9.
9
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
10
Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.急诊科使用电子健康记录数据识别脓毒症的时间:全身炎症反应综合征、序贯器官衰竭评估和快速序贯器官衰竭评估的比较分析。
Crit Care Med. 2020 Feb;48(2):200-209. doi: 10.1097/CCM.0000000000004132.